Susan Dentzer, senior policy adviser, Robert Wood Johnson Foundation, says there are many trends that are transforming today's health insurance marketplace.
Susan Dentzer, senior policy adviser, Robert Wood Johnson Foundation, says there are many trends that are transforming today’s health insurance marketplace. “First and foremost, we have all the arrays of reforms in Affordable Care Act that are finally putting the individual insurance market and the small group market on the same footing of the rest of health insurance,” said Ms Dentzer.
Other reforms including age rating compression, elimination of gender rating, and the existence of health insurance exchanges will help the industry to standardize levels of coverage as well as increase health plan transparency. Much more broadly, she says there have been a variety of payment and delivery system reforms in the ACA.
“The health insurance industry itself is morphing to a large degree into something very different,” suggested Ms Dentzer. “For many players in the industry they see their future as really being the ‘back office,’ in effect, for the nation’s ACOs and integrated delivery systems. It’s a very different role from the role of a classic insurer.”
California Aims for Equity by Redefining Cancer Care
December 8th 2023Authors highlight key aspects of the California Cancer Care Equity Act, including its focus on Medi-Cal beneficiaries, the requirement for managed care plans to contract with specialized cancer centers, and the definition of complex cancers.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Patients With RA in Remission Withdrawing From TNF Inhibition Show Flare Increases
December 8th 2023New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).
Read More